Kinnate Biopharma

YTD

ALL

Why Robinhood?

You can watch KNTE and buy or sell other stocks, ETFs, and their options commission-free!

About KNTE

Kinnate Biopharma, Inc. operates as a biopharmaceutical company engaged in the research and development of Kinnate Discovery Engine that targets genomic drivers of cancer. The company was founded by Stephen W.

CEO

Nima M. Farzan, MBA

CEONima M. Farzan, MBA

Employees

—

Employees—

Headquarters

San Diego, California

HeadquartersSan Diego, California

Founded

2018

Founded2018

Employees

—

Employees—

KNTE Key Statistics

Market cap

125.17M

Market cap125.17M

Price-Earnings ratio

-1.09

Price-Earnings ratio-1.09

Dividend yield

—

Dividend yield—

Average volume

367.46K

Average volume367.46K

High today

—

High today—

Low today

—

Low today—

Open price

—

Open price—

Volume

0.00

Volume0.00

52 Week high

$6.00

52 Week high$6.00

52 Week low

$1.04

52 Week low$1.04

People also own

Based on the portfolios of people who own KNTE. This list is generated using Robinhood data, and it’s not a recommendation.